Epkinly 48 mg/0.8 mL injection Images
Generic Name: epcoritamab
This medication has been identified as Epkinly 48 mg/0.8 mL injection. It is supplied by AbbVie Inc.
Epkinly is used in the treatment of Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; B-Cell Lymphoma and belongs to the drug class bispecific T-cell engagers (BiTE). Epkinly 48 mg/0.8 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Epkinly
- Generic Name
- epcoritamab
- Strength
- 48 mg/0.8 mL injection
- Availability
- Prescription only
- Drug Class
- Bispecific T-cell engagers (BiTE)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 82705-0010
More about Epkinly (epcoritamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
